Jennifer Pike, MD
Dermatology · Virginia Beach, VANPI 1154652345
Payments from drug & device makers
Across 98 payments — averaging $21.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$477
- Dermavant Sciences, Inc.$321
- Johnson & Johnson$314
- Novartis$286
- Sun Pharmaceutical Industries Inc.$113
- Regeneron Healthcare Solutions, Inc.$96
- plus $469 from 10 others
What the payments were for
- Food & beverage$1,81087%
- Education$26613%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $477 |
| Dermavant Sciences, Inc. | 16 | $321 |
| Johnson & Johnson | 7 | $314 |
| Novartis | 14 | $286 |
| Sun Pharmaceutical Industries Inc. | 4 | $113 |
| Regeneron Healthcare Solutions, Inc. | 6 | $96 |
| Galderma Laboratories, L.p. | 6 | $86 |
| LEO Pharma Inc. | 4 | $85 |
| Kerecis Limited | 2 | $71 |
| Pfizer | 4 | $58 |
| Sanofi | 3 | $55 |
| Bristol Myers Squibb | 2 | $40 |
| UCB, Inc. | 1 | $19 |
| Almirall LLC | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Biofrontera Inc. | 1 | $18 |
How this compares
$2,076 in reported general payments places this provider in the 50th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $46,779 |
| Dupixent SyringeDupilumab | 11 | $39,062 |
| Fluorouracil | 56 | $4,268 |
| Clobetasol Propionate | 53 | $3,706 |
| Fluocinonide | 35 | $1,274 |
| Ketoconazole | 69 | $956 |
| Metronidazole | 22 | $927 |
| Doxycycline Hyclate | 42 | $860 |
| Clindamycin Phosphate | 15 | $741 |
| ValacyclovirValacyclovir Hcl | 19 | $729 |
| Triamcinolone Acetonide | 55 | $525 |
| Minoxidil | 32 | $304 |
| Mupirocin | 23 | $196 |
| Hydrocortisone | 23 | $118 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Virginia Beach
- Diego DasilvaVirginia Beach$1.1M
- Cyndi Torosky TommasoVirginia Beach$717K
- Tara Buehler BotaVirginia Beach$21K
- David PariserNorfolk$7M
- Jennifer DesimoneFairfax$2.3M
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Vishal PatelLeesburg$1.1M
- Carrie CobbLynchburg$859K
- Yvonne KnightRichmond$857K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.